Which oral antihistamine can be prescribed for a 20‑month‑old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antihistamine Options for a 20-Month-Old Child

For a 20-month-old child requiring antihistamine therapy, cetirizine 0.25 mg/kg twice daily (approximately 2.5 mg twice daily for a typical 10 kg child) is the recommended oral antihistamine, as it is one of only two antihistamines with documented safety data and FDA approval for children under 2 years of age. 1, 2

FDA-Approved Options for This Age Group

  • Cetirizine is the primary choice for infants 6-11 months and toddlers up to 2 years, with a proven safety profile in a randomized, double-blind, placebo-controlled study specifically conducted in infants 6-11 months of age 2
  • The recommended dose is 0.25 mg/kg twice daily, which translates to approximately 2.5 mg twice daily for a typical 10 kg toddler 1
  • Cetirizine and loratadine are the only two antihistamines with FDA approval for children under 5 years of age 1

Alternative Second-Generation Antihistamine

  • Loratadine can be considered as an alternative, though it is typically dosed at 5 mg once daily for children aged 2-5 years 1, 3
  • For a 20-month-old (just under 2 years), loratadine dosing would require physician consultation, as most approval extends down to age 2 years 1

Critical Safety Warnings: What to Avoid

  • Never prescribe first-generation antihistamines (diphenhydramine, hydroxyzine) for routine allergic symptoms in children under 6 years due to significant safety concerns 1, 3
  • Between 1969-2006, there were 69 fatalities associated with antihistamines in children under 6 years, with 41 deaths occurring in children under 2 years, and diphenhydramine was responsible for 33 of these deaths 1, 3
  • The FDA and American Academy of Pediatrics explicitly recommend against using OTC cough and cold medications containing first-generation antihistamines in children below 6 years of age 1, 3
  • Intranasal antihistamines (azelastine, olopatadine) are only approved for children 12 years and older and should not be used in this age group 4, 1

Preferred First-Line Treatment Alternative

  • Intranasal corticosteroids are actually the most effective medication class for controlling all symptoms of allergic rhinitis in children under 2 years, with high-quality evidence supporting their use 1
  • When given in recommended doses, intranasal corticosteroids are not associated with clinically significant systemic side effects 1
  • Consider intranasal corticosteroids as first-line therapy, with cetirizine as second-line or adjunctive treatment 1

Practical Administration Considerations

  • Liquid formulations are strongly preferred in young children for easier administration and better absorption 3
  • Monitor for possible sedation with higher-than-usual doses of cetirizine, though this is uncommon at recommended dosing 1
  • Second-generation antihistamines like cetirizine have been shown to be well-tolerated with excellent safety profiles in young children 1, 5, 6

Common Pitfall to Avoid

  • Do not use antihistamines "to make a child sleepy"—this is explicitly contraindicated per FDA labeling 3
  • Avoid OTC cough and cold combination products in children under 6 years due to overdose risk 3
  • Oral decongestants (pseudoephedrine, phenylephrine) should be used with extreme caution in infants and young children, as use has been associated with agitated psychosis, ataxia, hallucinations, and even death 4

References

Guideline

Alternatives to Cetirizine for Allergic Rhinitis in Children Under 2 Years

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Antihistamine Dosing for Pediatric Allergic Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antihistamines: ABC for the pediatricians.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.